Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
GENADYNE BIOTECHNOLOGIES, INC.
*STREET
16 MIDLAND AVENUE
*CITY
HICKSVILLE
*STATE
(Required for U.S. applicants)
New York
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
11801
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
New York
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
010
*IDENTIFICATION
Negative Pressure Wound Therapy Device; Medical and therapeutic devices, equipment and supplies, namely, negative pressure wound therapy
systems comprised primarily of dressing kits composed primarily of silver antimicrobial foam dressings, PU foam dressings, collagen dressings, silicone port pad, transparent film dressings,
canisters, and related parts and fittings for the aforementioned goods;
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88097915
Filing Date:08/29/2018
To the Commissioner for Trademarks:
MARK: XLR8 (Standard Characters, see mark)
The literal element of the mark consists of XLR8.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, GENADYNE BIOTECHNOLOGIES, INC., a corporation of New York, having an address of
16 MIDLAND AVENUE
HICKSVILLE, New York 11801
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 010: Negative Pressure Wound Therapy Device; Medical and therapeutic devices, equipment and supplies, namely, negative pressure wound
therapy systems comprised primarily of dressing kits composed primarily of silver antimicrobial foam dressings, PU foam dressings, collagen dressings, silicone port pad, transparent film dressings,
canisters, and related parts and fittings for the aforementioned goods;
In International Class 010, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 04/29/2009, and first used in
commerce at least as early as 04/29/2009, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) picture of product with mark displayed on screen. Specimen File1 Specimen File2
The applicant's current Attorney Information:
SARA M. DORCHAK and STEWART J. BELLUS of COLLARD & ROE, P.C. 1077 NORTHERN BOULEVARD
ROSLYN, New York 11576
United States
516-365-9802(phone)
5163659805(fax)
law@collardroe.com (authorized)
The applicant's current Correspondence Information:
SARA M. DORCHAK
COLLARD & ROE, P.C.
1077 NORTHERN BOULEVARD
ROSLYN, New York 11576
516-365-9802(phone)
5163659805(fax)
law@collardroe.com;sdorchak@collardroe.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /smd/ Date: 08/29/2018
Signatory's Name: Sara M. Dorchak
Signatory's Position: Attorney of Record, New York bar member
Payment Sale Number: 88097915
Payment Accounting Date: 08/30/2018
Serial Number: 88097915
Internet Transmission Date: Wed Aug 29 17:23:44 EDT 2018
TEAS Stamp: USPTO/BAS-XX.XX.XX.XXX-20180829172344756
301-88097915-61070c2f03273947f0f389b980e
ab64b18919dc859229c24c16bf45eacb954e2a-C
C-4260-20180829171724817584